{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:09:15Z","timestamp":1781766555626,"version":"3.54.5"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We investigated relationships among chimeric TCR (cTCR) expression density, target Ag density, and cTCR triggering to predict lysis of target cells by cTCR+ CD8+ T human cells as a function of Ag density. Triggering of cTCR and canonical TCR by Ag could be quantified by the same mathematical equation, but cTCR represented a special case in which serial triggering was abrogated. The magnitude of target lysis could be predicted as a function of cTCR triggering, and the predicted minimum cTCR density required for maximal target lysis by CD20-specific cTCR was experimentally tested. cTCR density below \u223c20,000 cTCR\/cell impaired target lysis, but increasing cTCR expression above this density did not improve target lysis or Ag sensitivity. cTCR downmodulation to densities below this critical minimum by interaction with Ag-expressing targets limited the sequential lysis of targets in a manner that could be predicted based on the number of cTCRs remaining. In contrast, acute inhibition of lysis of primary, intended targets (e.g., leukemic B cells) due to the presence of an excess of secondary targets (e.g., normal B cells) was dependent on the Ag density of the secondary target but occurred at Ag densities insufficient to promote significant cTCR downmodulation, suggesting a role for functional exhaustion rather than insufficient cTCR density. This suggests increasing cTCR density above a critical threshold may enhance sequential lysis of intended targets in isolation, but will not overcome the functional exhaustion of cTCR+ T cells encountered in the presence of secondary targets with high Ag density.<\/jats:p>","DOI":"10.4049\/jimmunol.0903701","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T03:13:55Z","timestamp":1268277235000},"page":"4284-4294","source":"Crossref","is-referenced-by-count":27,"title":["Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation"],"prefix":"10.1093","volume":"184","author":[{"given":"Scott E.","family":"James","sequence":"first","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"},{"name":"\u2020Division of Oncology, Department of Medicine and"},{"name":"\u2021Department of Immunology, University of Washington, Seattle, WA 98195; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"},{"name":"\u2020Division of Oncology, Department of Medicine and"},{"name":"\u2021Department of Immunology, University of Washington, Seattle, WA 98195; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Jensen","sequence":"additional","affiliation":[{"name":"\u00a7City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Lin","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjuan","family":"Wang","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua E.","family":"Budde","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"},{"name":"\u2020Division of Oncology, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Till","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"},{"name":"\u2020Division of Oncology, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Raubitschek","sequence":"additional","affiliation":[{"name":"\u00a7City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[{"name":"\u00a7City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver W.","family":"Press","sequence":"additional","affiliation":[{"name":"*Fred Hutchinson Cancer Research Center, Seattle, WA 98109;"},{"name":"\u2020Division of Oncology, Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,15]]},"reference":[{"key":"2023010203223371100_r1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc971","article-title":"Targeting tumours with genetically enhanced T lymphocytes.","volume":"3","author":"Sadelain","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"2023010203223371100_r2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2009.02.009","article-title":"The promise and potential pitfalls of chimeric antigen receptors.","volume":"21","author":"Sadelain","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"2023010203223371100_r3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm827","article-title":"Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.","volume":"9","author":"Brentjens","year":"2003","journal-title":"Nat. Med."},{"key":"2023010203223371100_r4","doi-asserted-by":"crossref","first-page":"19051","DOI":"10.1073\/pnas.0504312102","article-title":"Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.","volume":"102","author":"Westwood","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010203223371100_r5","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.173.3.2143","article-title":"Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.","volume":"173","author":"Kershaw","year":"2004","journal-title":"J. Immunol."},{"key":"2023010203223371100_r6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.166.1.182","article-title":"Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma.","volume":"166","author":"Haynes","year":"2001","journal-title":"J. Immunol."},{"key":"2023010203223371100_r7","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.164.7.3705","article-title":"Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.","volume":"164","author":"Darcy","year":"2000","journal-title":"J. Immunol."},{"key":"2023010203223371100_r8","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2007-12-128843","article-title":"Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.","volume":"112","author":"Till","year":"2008","journal-title":"Blood"},{"key":"2023010203223371100_r9","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1200\/JCO.2006.05.9964","article-title":"Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.","volume":"24","author":"Lamers","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"2023010203223371100_r10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.mt.6300104","article-title":"Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.","volume":"15","author":"Park","year":"2007","journal-title":"Mol. Ther."},{"key":"2023010203223371100_r11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.","volume":"14","author":"Pule","year":"2008","journal-title":"Nat. Med."},{"key":"2023010203223371100_r12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/10430349950018634","article-title":"Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies.","volume":"10","author":"Alvarez-Vallina","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"2023010203223371100_r13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.gt.3301051","article-title":"Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.","volume":"7","author":"Weijtens","year":"2000","journal-title":"Gene Ther."},{"key":"2023010203223371100_r14","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.4049\/jimmunol.180.10.7028","article-title":"Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.","volume":"180","author":"James","year":"2008","journal-title":"J. Immunol."},{"key":"2023010203223371100_r15","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1182\/blood-2009-08-232967","article-title":"Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.","volume":"114","author":"James","year":"2009","journal-title":"Blood"},{"key":"2023010203223371100_r16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(90)90210-M","article-title":"The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.","volume":"128","author":"Riddell","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"2023010203223371100_r17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/bbmt.1998.v4.pm9763110","article-title":"CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy.","volume":"4","author":"Jensen","year":"1998","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2023010203223371100_r18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ymthe.2003.12.011","article-title":"Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.","volume":"9","author":"Wang","year":"2004","journal-title":"Mol. Ther."},{"key":"2023010203223371100_r19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.273.5271.104","article-title":"T cell activation determined by T cell receptor number and tunable thresholds.","volume":"273","author":"Viola","year":"1996","journal-title":"Science"},{"key":"2023010203223371100_r20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/375148a0","article-title":"Serial triggering of many T-cell receptors by a few peptide-MHC complexes.","volume":"375","author":"Valitutti","year":"1995","journal-title":"Nature"},{"key":"2023010203223371100_r21","first-page":"113","article-title":"Notice sur la loi que la population poursuit dans son accroissement.","volume":"10","author":"Verhulst","year":"1838","journal-title":"Correspondance math\u00e9matique physique"},{"key":"2023010203223371100_r22","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.4049\/jimmunol.162.4.2073","article-title":"Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.","volume":"162","author":"Itoh","year":"1999","journal-title":"J. Immunol."},{"key":"2023010203223371100_r23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/85286","article-title":"Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex.","volume":"2","author":"Kalergis","year":"2001","journal-title":"Nat. Immunol."},{"key":"2023010203223371100_r24","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2571::AID-IMMU2571>3.0.CO;2-T","article-title":"Formation of TCR dimers\/trimers as a crucial step for T cell activation.","volume":"28","author":"Bachmann","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"2023010203223371100_r25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/eji.1830250432","article-title":"Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.","volume":"25","author":"Isaaz","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"2023010203223371100_r26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/cimm.1996.0101","article-title":"Conjugation between cloned human NK cells (H7.8) and K562\/MOLT4 tumor cell systems: saturability, binding parameters, and population distribution of conjugates.","volume":"169","author":"Cabrera","year":"1996","journal-title":"Cell. Immunol."},{"key":"2023010203223371100_r27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2009.03.010","article-title":"The cellular context of T cell signaling.","volume":"30","author":"Dustin","year":"2009","journal-title":"Immunity"},{"key":"2023010203223371100_r28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nri959","article-title":"Progressive differentiation and selection of the fittest in the immune response.","volume":"2","author":"Lanzavecchia","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2023010203223371100_r29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ni1369","article-title":"The kinetic-segregation model: TCR triggering and beyond.","volume":"7","author":"Davis","year":"2006","journal-title":"Nat. Immunol."},{"key":"2023010203223371100_r30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coi.2006.03.011","article-title":"Immune synapses in T-cell activation.","volume":"18","author":"Cemerski","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"2023010203223371100_r31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.smim.2007.04.005","article-title":"Molecular mechanisms involved in T cell receptor triggering.","volume":"19","author":"Choudhuri","year":"2007","journal-title":"Semin. Immunol."},{"key":"2023010203223371100_r32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ni838","article-title":"Activated TCRs remain marked for internalization after dissociation from pMHC.","volume":"3","author":"Coombs","year":"2002","journal-title":"Nat. Immunol."},{"key":"2023010203223371100_r33","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1073\/pnas.0500922102","article-title":"T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.","volume":"102","author":"Gonz\u00e1lez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010203223371100_r34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.184.4.1525","article-title":"Selective activation of the calcium signaling pathway by altered peptide ligands.","volume":"184","author":"Sloan-Lancaster","year":"1996","journal-title":"J. Exp. Med."},{"key":"2023010203223371100_r35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ni895","article-title":"TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.","volume":"4","author":"Stefanov\u00e1","year":"2003","journal-title":"Nat. Immunol."},{"key":"2023010203223371100_r36","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.1073\/pnas.0600651103","article-title":"Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses.","volume":"103","author":"Wiedemann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010203223371100_r37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T cells.","volume":"8","author":"Iezzi","year":"1998","journal-title":"Immunity"},{"key":"2023010203223371100_r38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.","volume":"198","author":"Overwijk","year":"2003","journal-title":"J. Exp. Med."},{"key":"2023010203223371100_r39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4049\/jimmunol.172.1.104","article-title":"Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.","volume":"172","author":"Finney","year":"2004","journal-title":"J. Immunol."},{"key":"2023010203223371100_r40","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.","volume":"106","author":"Carpenito","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023010203223371100_r41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.","volume":"17","author":"Milone","year":"2009","journal-title":"Mol. Ther."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.aai.org\/jimmunol\/article-pdf\/184\/8\/4284\/1321267\/ji_0903701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.aai.org\/jimmunol\/article-pdf\/184\/8\/4284\/1321267\/ji_0903701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:58:01Z","timestamp":1735840681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.aai.org\/jimmunol\/article\/184\/8\/4284\/82730\/Mathematical-Modeling-of-Chimeric-TCR-Triggering"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,15]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,4,15]]},"published-print":{"date-parts":[[2010,4,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0903701","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,15]]}}}